Christophe Vandenbriele, MD, discusses data on combining Impella® with MitraClip to optimize outcomes in cardiogenic shock with acute severe mitral regurgitation secondary to AMI.
Dave Weber, PhD, reviews how SmartAssist technology determines and tracks trends in cardiac output (CO) and cardiac power output (CPO) and how these metrics can be used to guide a successful Impella® heart pump weaning procedure.
Marvin Slepian, MD, compares the hemocompatibility of Impella 5.5 to Centrimag discussing hemolysis, platelet activation, microparticle generation, and vWF alteration.
William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock.